adminの記事一覧

Additive antioxidative effects of azelnidipine on angiotensin receptor blocker olmesartan treatment for type 2 diabetic patients with albuminuria.

Hypertens Res . 34: 935-941, 2011.PubMed

Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass.

J Am Coll Cardiol. 58(22): 2301-2309, 2011.PubMed

Protective effects of tubular liver-type fatty acid-binding protein against glomerular damage in murine IgA nephropathy.

Nephrol Dial Transplant. 26(7): 2127-2137, 2011.PubMed

Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.

Am J Pathol. 178(3): 1021-1032, 2011.PubMed

Clinical significance of tubular and podocyte biomarkers in acute kidney injury.

Clin Exp Nephrol. 15(2): 220-225, 2011.PubMed

Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis.

Nephrol Dial Transplant. 26(11): 3465-3473, 2011.PubMed

Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients.

Diabetes Care. 34(3): 691-696, 2011.PubMed

Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit.

Crit Care Med. 39(11): 2464-2469, 2011.PubMed

Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury.

Crit Care Med. 38(10): 2037-2042, 2010PubMed

Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes.

Eur J Clin Invest. 40(2): 95-102, 2010.PubMed